Baqsimi™ (glucagon) nasal powder

3mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

BAQSIMI™ (glucagon) nasal powder: Mechanism of Action

Glucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver.

Detailed Information

Glucagon increases BG concentration by activating hepatic glucagon receptors, thereby stimulating

  • hepatic glycogen breakdown and

  • the release of glucose from the liver.1

Hepatic stores of glycogen are necessary for glucagon to produce an antihypoglycemic effect.1

Enclosed Prescribing Information

BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly

Reference

1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

BG = blood glucose

Date of Last Review: July 24, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical